180 related articles for article (PubMed ID: 24225187)
1. MicroRNA-gene signaling pathways in pancreatic cancer.
Drakaki A; Iliopoulos D
Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
[TBL] [Abstract][Full Text] [Related]
2. Emerging drugs in the treatment of pancreatic cancer.
Mahalingam D; Kelly KR; Swords RT; Carew J; Nawrocki ST; Giles FJ
Expert Opin Emerg Drugs; 2009 Jun; 14(2):311-28. PubMed ID: 19466902
[TBL] [Abstract][Full Text] [Related]
3. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
[TBL] [Abstract][Full Text] [Related]
4. The role of phosphatidylinositol 3-kinase signaling pathways in pancreatic cancer.
Sun C; Rosendahl AH; Andersson R; Wu D; Wang X
Pancreatology; 2011; 11(2):252-60. PubMed ID: 21625196
[TBL] [Abstract][Full Text] [Related]
5. A review of systemic therapy for advanced pancreatic cancer.
El-Rayes BF; Philip PA
Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic targeting in pancreatic cancer.
van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
[TBL] [Abstract][Full Text] [Related]
7. Molecular alterations contributing to pancreatic cancer chemoresistance.
Rajabpour A; Rajaei F; Teimoori-Toolabi L
Pancreatology; 2017; 17(2):310-320. PubMed ID: 28065383
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
9. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
10. Core signaling pathways and new therapeutic targets in pancreatic cancer.
You L; Chen G; Zhao YP
Chin Med J (Engl); 2010 May; 123(9):1210-5. PubMed ID: 20529565
[TBL] [Abstract][Full Text] [Related]
11. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer.
El Maalouf G; Le Tourneau C; Batty GN; Faivre S; Raymond E
Cancer Treat Rev; 2009 Apr; 35(2):167-74. PubMed ID: 19027240
[TBL] [Abstract][Full Text] [Related]
12. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Cancer Stem Cells and Therapeutic Approaches.
Ercan G; Karlitepe A; Ozpolat B
Anticancer Res; 2017 Jun; 37(6):2761-2775. PubMed ID: 28551612
[TBL] [Abstract][Full Text] [Related]
14. The role of p21-activated kinases in pancreatic cancer.
Yeo D; He H; Baldwin GS; Nikfarjam M
Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
[TBL] [Abstract][Full Text] [Related]
15. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
16. Prospects of miRNA-based therapy for pancreatic cancer.
Pai P; Rachagani S; Are C; Batra SK
Curr Drug Targets; 2013 Sep; 14(10):1101-9. PubMed ID: 23834151
[TBL] [Abstract][Full Text] [Related]
17. Treatment options for advanced pancreatic cancer: a review.
Warsame R; Grothey A
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1327-36. PubMed ID: 23176620
[TBL] [Abstract][Full Text] [Related]
18. Drugs in preclinical and early-stage clinical development for pancreatic cancer.
Asuthkar S; Rao JS; Gondi CS
Expert Opin Investig Drugs; 2012 Feb; 21(2):143-52. PubMed ID: 22217246
[TBL] [Abstract][Full Text] [Related]
19. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokines in human pancreatic cancer.
Roshani R; McCarthy F; Hagemann T
Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]